Creso Pharma Limited filed its Annual on Feb 28, 2022 for the period ending Dec 31, 2021. In this report its auditor, BDO LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 AUD | +25.00% | +25.00% | -87.50% |
1st Jan change | Capi. | |
---|---|---|
-87.50% | 1.06M | |
+33.77% | 701B | |
+26.24% | 571B | |
+1.29% | 381B | |
+21.03% | 334B | |
+16.85% | 319B | |
+1.26% | 210B | |
+2.58% | 210B | |
-6.50% | 201B | |
-3.21% | 157B |
- Stock
- Equities
- Stock Melodiol Global Health Limited - Australian S.E.
- News Melodiol Global Health Limited
- Creso Pharma Limited Auditor Raises 'Going Concern' Doubt